209 related articles for article (PubMed ID: 15519239)
1. Dimerization of Parkinson's disease-causing DJ-1 and formation of high molecular weight complexes in human brain.
Baulac S; LaVoie MJ; Strahle J; Schlossmacher MG; Xia W
Mol Cell Neurosci; 2004 Nov; 27(3):236-46. PubMed ID: 15519239
[TBL] [Abstract][Full Text] [Related]
2. The DJ-1L166P mutant protein associated with early onset Parkinson's disease is unstable and forms higher-order protein complexes.
Macedo MG; Anar B; Bronner IF; Cannella M; Squitieri F; Bonifati V; Hoogeveen A; Heutink P; Rizzu P
Hum Mol Genet; 2003 Nov; 12(21):2807-16. PubMed ID: 12952867
[TBL] [Abstract][Full Text] [Related]
3. Pink1, Parkin, DJ-1 and mitochondrial dysfunction in Parkinson's disease.
Dodson MW; Guo M
Curr Opin Neurobiol; 2007 Jun; 17(3):331-7. PubMed ID: 17499497
[TBL] [Abstract][Full Text] [Related]
4. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
[TBL] [Abstract][Full Text] [Related]
5. Parkinson's disease-associated mutations in DJ-1 modulate its dimerization in living cells.
Repici M; Straatman KR; Balduccio N; Enguita FJ; Outeiro TF; Giorgini F
J Mol Med (Berl); 2013 May; 91(5):599-611. PubMed ID: 23183826
[TBL] [Abstract][Full Text] [Related]
6. Reduced protein stability of human DJ-1/PARK7 L166P, linked to autosomal recessive Parkinson disease, is due to direct endoproteolytic cleavage by the proteasome.
Alvarez-Castelao B; Muñoz C; Sánchez I; Goethals M; Vandekerckhove J; Castaño JG
Biochim Biophys Acta; 2012 Feb; 1823(2):524-33. PubMed ID: 22173095
[TBL] [Abstract][Full Text] [Related]
7. DJ-1 associates with lipid rafts by palmitoylation and regulates lipid rafts-dependent endocytosis in astrocytes.
Kim KS; Kim JS; Park JY; Suh YH; Jou I; Joe EH; Park SM
Hum Mol Genet; 2013 Dec; 22(23):4805-17. PubMed ID: 23847046
[TBL] [Abstract][Full Text] [Related]
8. Localization of DJ-1 protein in the murine brain.
Kotaria N; Hinz U; Zechel S; von Bohlen Und Halbach O
Cell Tissue Res; 2005 Dec; 322(3):503-7. PubMed ID: 16047164
[TBL] [Abstract][Full Text] [Related]
9. DJ-1 and prevention of oxidative stress in Parkinson's disease and other age-related disorders.
Kahle PJ; Waak J; Gasser T
Free Radic Biol Med; 2009 Nov; 47(10):1354-61. PubMed ID: 19686841
[TBL] [Abstract][Full Text] [Related]
10. DJ-1 associates with synaptic membranes.
Usami Y; Hatano T; Imai S; Kubo S; Sato S; Saiki S; Fujioka Y; Ohba Y; Sato F; Funayama M; Eguchi H; Shiba K; Ariga H; Shen J; Hattori N
Neurobiol Dis; 2011 Sep; 43(3):651-62. PubMed ID: 21645620
[TBL] [Abstract][Full Text] [Related]
11. DJ-1, a causative gene product of a familial form of Parkinson's disease, is secreted through microdomains.
Tsuboi Y; Munemoto H; Ishikawa S; Matsumoto K; Iguchi-Ariga SM; Ariga H
FEBS Lett; 2008 Jul; 582(17):2643-9. PubMed ID: 18586035
[TBL] [Abstract][Full Text] [Related]
12. Loss of DJ-1 protein stability and cytoprotective function by Parkinson's disease-associated proline-158 deletion.
Rannikko EH; Vesterager LB; Shaik JH; Weber SS; Cornejo Castro EM; Fog K; Jensen PH; Kahle PJ
J Neurochem; 2013 Apr; 125(2):314-27. PubMed ID: 23241025
[TBL] [Abstract][Full Text] [Related]
13. DJ-1 and UCH-L1 gene activity patterns in the brains of controls, Parkinson and schizophrenia patients and in rodents.
Galter D; Westerlund M; Belin AC; Olson L
Physiol Behav; 2007 Sep; 92(1-2):46-53. PubMed ID: 17599367
[TBL] [Abstract][Full Text] [Related]
14. Roles of distinct cysteine residues in S-nitrosylation and dimerization of DJ-1.
Ito G; Ariga H; Nakagawa Y; Iwatsubo T
Biochem Biophys Res Commun; 2006 Jan; 339(2):667-72. PubMed ID: 16316629
[TBL] [Abstract][Full Text] [Related]
15. DJ-1: a newcomer in Parkinson's disease pathology.
da Costa CA
Curr Mol Med; 2007 Nov; 7(7):650-7. PubMed ID: 18045143
[TBL] [Abstract][Full Text] [Related]
16. The expression of DJ-1 (PARK7) in normal human CNS and idiopathic Parkinson's disease.
Bandopadhyay R; Kingsbury AE; Cookson MR; Reid AR; Evans IM; Hope AD; Pittman AM; Lashley T; Canet-Aviles R; Miller DW; McLendon C; Strand C; Leonard AJ; Abou-Sleiman PM; Healy DG; Ariga H; Wood NW; de Silva R; Revesz T; Hardy JA; Lees AJ
Brain; 2004 Feb; 127(Pt 2):420-30. PubMed ID: 14662519
[TBL] [Abstract][Full Text] [Related]
17. Pink1 Parkinson mutations, the Cdc37/Hsp90 chaperones and Parkin all influence the maturation or subcellular distribution of Pink1.
Weihofen A; Ostaszewski B; Minami Y; Selkoe DJ
Hum Mol Genet; 2008 Feb; 17(4):602-16. PubMed ID: 18003639
[TBL] [Abstract][Full Text] [Related]
18. Loss of function of DJ-1 triggered by Parkinson's disease-associated mutation is due to proteolytic resistance to caspase-6.
Giaime E; Sunyach C; Druon C; Scarzello S; Robert G; Grosso S; Auberger P; Goldberg MS; Shen J; Heutink P; Pouysségur J; Pagès G; Checler F; Alves da Costa C
Cell Death Differ; 2010 Jan; 17(1):158-69. PubMed ID: 19680261
[TBL] [Abstract][Full Text] [Related]
19. DJ-1 interactions with α-synuclein attenuate aggregation and cellular toxicity in models of Parkinson's disease.
Zondler L; Miller-Fleming L; Repici M; Gonçalves S; Tenreiro S; Rosado-Ramos R; Betzer C; Straatman KR; Jensen PH; Giorgini F; Outeiro TF
Cell Death Dis; 2014 Jul; 5(7):e1350. PubMed ID: 25058424
[TBL] [Abstract][Full Text] [Related]
20. Reduced anti-oxidative stress activities of DJ-1 mutants found in Parkinson's disease patients.
Takahashi-Niki K; Niki T; Taira T; Iguchi-Ariga SM; Ariga H
Biochem Biophys Res Commun; 2004 Jul; 320(2):389-97. PubMed ID: 15219840
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
